Navigation Links
Sepsis treatment functions best in difficult cases

According to a new analysis suggests that anti-inflammatory agents work best in cases of sepsis which are life-threatening. Sepsis is a condition of overwhelming infection, in which bacteria invade the blood stream.// It is potentially fatal, because it carries the risk of multiple organ failure. In fact, sepsis claims many lives in the intensive care unit, because patients here are very vulnerable to infection.

Treatment is usually by anti-inflammatory agents, which can damp down the infection. But success of anti-inflammatory agents is variable. Researchers in the US carried out a large retrospective study, covering 20 clinical trials and 35 pre-clinical trials on animals. This revealed that anti-inflammatory agents were most effective when the patient was thought to have the highest risk of death from sepsis. If the risk of death was low, the patient could actually be harmed by anti-inflammatory agents. The researchers then confirmed their findings with tests involving 1,125 rats, exposed to varying doses of anti-inflammatory agents.


'"/>




Page: 1

Related medicine news :

1. Sepsis Death Reported With Mifepristone – FDA Issues Warnin
2. Researchers identify the early makers of Neonatal Sepsis
3. Sepsis risk increased due to the absence of one key enzyme
4. Drexel Research in Cytokines Could Treat Sepsis
5. Thyroid hormone treatment hastens recovery after cardiac surgery
6. Feeding channel created by malaria parasite - a new target for malaria treatments
7. Now umbilical cord helps in stroke treatment.
8. Now AIDS treatment comes dirt-cheap
9. Breast cancer treatment to be determined by gene test
10. Hemopurifier may revolutionise AIDS treatment
11. New drug helps boost cancer treatment
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... ... ... Reltok Nasal Products proudly announces that Boston Medical Products, Inc., a leading ... specialty, has added the KOTLER NASAL AIRWAY™ to its diverse product line. , A ... safety device secured by nasal surgeons onto the floor of the nasal passages, at ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the market leader ... led by Eastside Partners, with participation from existing investor Martin Ventures. The ... accelerate its technology and product roadmap. , “Jvion is experiencing significant ...
(Date:4/29/2016)... ... April 29, 2016 , ... Regenerative Medicine Solutions (RMS) scored ... satisfaction survey, earning them second place for Tampa’s Best Places to Work. They were ... “This is a great accomplishment for our team,” says RMS Human Resources Manager Irene ...
(Date:4/29/2016)... ... April 29, 2016 , ... The infertility specialists at HRC Fertility/Orange County (HRC/OC) ... Daniel A. Potter -- are proud of the recent release of their 2014 in ... SART published the latest verified data for 375 U.S. member clinics. *Preliminary ...
(Date:4/29/2016)... ... April 29, 2016 , ... Natren, Inc. ... line of probiotics, Petbiotics ™, as they fondly call them. As animal ... groups networking for their non-profit organizations. Animal rescues across the nation face huge ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... 29, 2016 Acquisition Expands ... Product Development Capabilities in North America ... . Indegene ( http://www.indegene.com ), ... acquisition of Skura Corporation,s life science business. Skura,s ... sales enablement technology for life science organizations and ...
(Date:4/29/2016)... 29, 2016 ... Sanofi, leader mondial et ... résultats pour le premier trimestre 2016. ... Contamine, commente les résultats du premier ... pour le reste de l,année. ...
(Date:4/29/2016)... Glycotope GmbH, a clinical-stage immuno-oncology company built ... Dr. Alfredo Zurlo as Chief Medical Officer. ... years clinical experience and a proven track record in ... at Mologen AG where he was Chief Medical Officer ... held various positions at F Hoffmann La Roche and ...
Breaking Medicine Technology: